NYSE American - Delayed Quote USD

Can-Fite BioPharma Ltd. (CANF)

1.1100
-0.0050
(-0.45%)
At close: May 9 at 4:00:00 PM EDT
1.1086
-0.00
(-0.13%)
After hours: May 9 at 6:07:38 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
674
674
743
810
853
Operating Expense
8,804
8,804
8,938
10,906
13,695
Operating Income
-8,130
-8,130
-8,195
-10,096
-12,842
Net Non Operating Interest Income Expense
277
277
492
206
6
Other Income Expense
-27
-27
69
-283
221
Pretax Income
-7,880
-7,880
-7,634
-10,173
-12,615
Tax Provision
--
--
0
0
0
Net Income Common Stockholders
-7,880
-7,880
-7,634
-10,173
-15,205
Diluted NI Available to Com Stockholders
-7,880
-7,880
-7,634
-10,173
-15,205
Basic EPS
0.00
0.00
-3.00
-3.00
-9.00
Diluted EPS
0.00
0.00
-3.00
-3.00
-9.00
Basic Average Shares
7,253.0880
7,253.0880
4,261.1130
2,719.1540
1,843.5990
Diluted Average Shares
7,253.0880
7,253.0880
4,261.1130
2,719.1540
1,843.5990
Total Operating Income as Reported
-8,130
-8,130
-8,195
-10,096
-12,842
Total Expenses
8,804
8,804
8,938
10,906
13,695
Net Income from Continuing & Discontinued Operation
-7,880
-7,880
-7,634
-10,173
-12,615
Normalized Income
-7,853
-7,853
-7,703
-9,890
-12,836
Interest Income
291
291
506
222
24
Net Interest Income
277
277
492
206
6
EBIT
-8,130
-8,130
-8,195
-10,096
-12,842
EBITDA
-8,123
-8,123
-8,180
-10,082
-12,828
Reconciled Depreciation
7
7
15
14
14
Net Income from Continuing Operation Net Minority Interest
-7,880
-7,880
-7,634
-10,173
-12,615
Total Unusual Items Excluding Goodwill
-27
-27
69
-283
221
Total Unusual Items
-27
-27
69
-283
221
Normalized EBITDA
-8,096
-8,096
-8,249
-9,799
-13,049
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/6/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ENLV Enlivex Therapeutics Ltd.
1.0200
-2.86%
 
BLRX BioLineRx Ltd.
3.1700
-0.94%
 
PPBT Purple Biotech Ltd
2.2050
-0.68%
 
PLUR Pluri Inc.
5.75
+8.29%
 
INAB IN8bio, Inc.
0.1574
-6.25%
 
IRD Opus Genetics, Inc.
0.9468
-4.92%
 
CVM CEL-SCI Corporation
0.2468
-3.14%
 
NTHI NeOnc Technologies Holdings, Inc.
7.34
+11.21%
 
XTLB XTL Biopharmaceuticals Ltd.
1.2600
+1.61%
 
XFOR X4 Pharmaceuticals, Inc.
3.3700
+2.43%